Skip to Content

Join the 'Bimatoprost' group to help and get support from people like you.

Bimatoprost News

Related terms: Bimatoprost Topical

Generic Eye Drops for Seniors Could Save Millions of Dollars a Year

Posted 28 Jul 2017 by Drugs.com

FRIDAY, July 28, 2017 – Prescribing generic drugs for seniors' eye problems could save the U.S. government hundreds of millions of dollars a year, a new study suggests. Conditions like glaucoma and dry eye that require daily eye drops are common in old age. University of Michigan researchers report that eye doctors caring for seniors prescribe brand-name medications in more than three-quarters ...

Lupin Receives FDA Approval for Generic Lumigan Ophthalmic Solution 0.03%

Posted 23 Feb 2015 by Drugs.com

Mumbai, India and Baltimore, Maryland – February 23, 2015: Pharma Major Lupin Limited (Lupin) announced today that it has received final approval for its Bimatoprost Ophthalmic Solution, 0.03% from the United States Food and Drugs Administration (FDA) to market a generic version of Allergan Inc.'s Lumigan Ophthalmic Solution, 0.03%. Lupin Pharmaceuticals Inc. (LPI), the company's U.S. subsidiary ...

Illegal Online Meds Targeted in Worldwide Crackdown, FDA Says

Posted 25 May 2014 by Drugs.com

THURSDAY, May 22, 2014 – Illegal online pharmacies that sell unapproved and potentially dangerous prescription drugs to Americans were targeted this week in a worldwide operation, the U.S. Food and Drug Administration said Thursday. More than 19,600 packages containing medicines supposedly from Australia, Canada, New Zealand and Great Britain were seized in the action, which involved authorities ...

Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds

Posted 24 May 2013 by Drugs.com

FRIDAY, May 24 – Drugs commonly used to treat glaucoma may cause droopy eyelids and other side effects that can interfere with vision, according to a new study. The drugs, known as prostaglandin analogues (PGAs), which are used to reduce eye pressure, have already been shown to cause blurred vision, dryness and changes in eye color, the researchers said, suggesting that the new findings could ...

Allergan, Inc. Receives FDA Approval for Lumigan 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients

Posted 5 Sep 2010 by Drugs.com

IRVINE, Calif.--(BUSINESS WIRE)--Aug 31, 2010 - Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved Lumigan (bimatoprost ophthalmic solution) 0.01% as a first-line therapy indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Lumigan 0.01% is an optimized reformulation of Lumigan ...

Ask a Question

Further Information

Related Condition Support Groups

Intraocular Hypertension, Glaucoma (Open Angle)

Related Drug Support Groups

Lumigan

Bimatoprost Patient Information at Drugs.com